VCM
ROIV icon

Versant Capital Management’s Roivant Sciences ROIV Stock Holding History

Versant Capital Management’s Portfolio ROIV Stock Details ROIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$141K Buy
3,995
+487
+14% +$14.4K 0.01% 767
2026
Q1 		$97.2K Buy
3,508
+53
+2% +$1.36K 0.01% 876
2025
Q4 		$75K Buy
3,455
+27
+0.8% +$533 0.01% 882
2025
Q3 		$51.9K Hold
3,428
– – 0.01% 1018
2025
Q2 		$38.6K Buy
3,428
+1,323
+63% +$14.3K 0.01% 1126
2025
Q1 		$21.2K Buy
2,105
+1,898
+917% +$20.5K ﹤0.01% 1318
2024
Q4 		$2.45K Buy
+207
New +$2.45K ﹤0.01% 2006
2024
Q3 		– Sell
-257
Closed -$2.72K – 2070
2024
Q2 		$2.72K Buy
+257
New +$2.82K ﹤0.01% 1425

Other funds holding ROIV

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
QF
QVT Financial New York $1.7B AUM 173.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

Versant Capital Management's ROIV Position: Q2 2026 in Review

Versant Capital Management increased its Roivant Sciences (ROIV) stake by 14% in Q2 2026, buying an estimated $14.4K and bringing the position to 3,995 shares worth $141K. The position accounts for 0.01% of the portfolio, ranked #767.

Versant Capital Management first reported a position in ROIV in Q2 2024 and has held it in 8 quarters since. 498 funds tracked by Wall St. Rank hold ROIV as of Q2 2026.

  • Versant Capital Management held 3,995 shares of Roivant Sciences worth $141K as of Q2 2026.
  • Versant Capital Management bought 487 Roivant Sciences shares in Q2 2026, an estimated $14.4K.
  • Roivant Sciences made up 0.01% of Versant Capital Management's portfolio in Q2 2026, its #767 holding.
  • Versant Capital Management first reported a position in Roivant Sciences in Q2 2024 and has held it in 8 quarters since.
  • 498 funds tracked by Wall St. Rank held Roivant Sciences as of Q2 2026.

Based on Versant Capital Management's 13F filing for Q2 2026, filed 2 Jul 2026.